The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism.
Saved in:
| Title: | The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism. |
|---|---|
| Authors: | Tanner CM; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA. caroline.tanner@ucsf.edu.; Parkinson's Disease Research Education and Clinical Center, San Francisco Veteran's Affairs Health Care System, San Francisco, CA, USA. caroline.tanner@ucsf.edu., Cummings SR; San Francisco Coordinating Center,California Pacific Medical Center Research Institute, Departments of Medicine and Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA, USA., Schwarzschild MA; MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Brown EG; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA., Dorsey ER; Center for Health + Technology and Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA., Espay AJ; James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH, USA., Galifianakis NB; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA., Goldman SM; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.; Division of Occupational and Environmental Medicine, University of California San Francisco, San Francisco Veterans Affairs Health Care System, San Francisco, CA, USA., Litvan I; Parkinson and Other Movement Disorders Center, Department of Neuroscience, University of California San Diego, La Jolla, CA, USA., Luthra N; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA., McFarland NR; Norman Fixel Institute for Neurological Diseases, Department of Neurology, University of Florida College of Medicine, Gainesville, FL, USA., Mitchell KT; Department of Neurology, Duke University School of Medicine, Durham, NC, USA., Standaert DG; Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA., Bauer DC; Departments of Medicine and Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA, USA., Greenspan SL; Osteoporosis Prevention and Treatment Center, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Beck JC; Parkinson's Foundation, New York, NY, USA., Lyles KW; Department of Medicine, Duke University School of Medicine, VA Medical Center, Durham, NC, USA. |
| Source: | NPJ Parkinson's disease [NPJ Parkinsons Dis] 2021 Mar 01; Vol. 7 (1), pp. 16. Date of Electronic Publication: 2021 Mar 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101675390 Publication Model: Electronic Cited Medium: Print ISSN: 2373-8057 (Print) Linking ISSN: 23738057 NLM ISO Abbreviation: NPJ Parkinsons Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33649343 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tanner+CM%22">Tanner CM</searchLink>; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA. caroline.tanner@ucsf.edu.; Parkinson's Disease Research Education and Clinical Center, San Francisco Veteran's Affairs Health Care System, San Francisco, CA, USA. caroline.tanner@ucsf.edu.<br /><searchLink fieldCode="AU" term="%22Cummings+SR%22">Cummings SR</searchLink>; San Francisco Coordinating Center,California Pacific Medical Center Research Institute, Departments of Medicine and Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Schwarzschild+MA%22">Schwarzschild MA</searchLink>; MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Brown+EG%22">Brown EG</searchLink>; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Dorsey+ER%22">Dorsey ER</searchLink>; Center for Health + Technology and Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA.<br /><searchLink fieldCode="AU" term="%22Espay+AJ%22">Espay AJ</searchLink>; James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH, USA.<br /><searchLink fieldCode="AU" term="%22Galifianakis+NB%22">Galifianakis NB</searchLink>; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Goldman+SM%22">Goldman SM</searchLink>; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.; Division of Occupational and Environmental Medicine, University of California San Francisco, San Francisco Veterans Affairs Health Care System, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Litvan+I%22">Litvan I</searchLink>; Parkinson and Other Movement Disorders Center, Department of Neuroscience, University of California San Diego, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Luthra+N%22">Luthra N</searchLink>; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22McFarland+NR%22">McFarland NR</searchLink>; Norman Fixel Institute for Neurological Diseases, Department of Neurology, University of Florida College of Medicine, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Mitchell+KT%22">Mitchell KT</searchLink>; Department of Neurology, Duke University School of Medicine, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Standaert+DG%22">Standaert DG</searchLink>; Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Bauer+DC%22">Bauer DC</searchLink>; Departments of Medicine and Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Greenspan+SL%22">Greenspan SL</searchLink>; Osteoporosis Prevention and Treatment Center, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Beck+JC%22">Beck JC</searchLink>; Parkinson's Foundation, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lyles+KW%22">Lyles KW</searchLink>; Department of Medicine, Duke University School of Medicine, VA Medical Center, Durham, NC, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101675390%22">NPJ Parkinson's disease</searchLink> [NPJ Parkinsons Dis] 2021 Mar 01; Vol. 7 (1), pp. 16. <i>Date of Electronic Publication: </i>2021 Mar 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101675390 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2373-8057 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223738057%22">23738057 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Parkinsons Dis <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33649343 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41531-021-00162-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 16 Titles: – TitleFull: The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tanner CM – PersonEntity: Name: NameFull: Cummings SR – PersonEntity: Name: NameFull: Schwarzschild MA – PersonEntity: Name: NameFull: Brown EG – PersonEntity: Name: NameFull: Dorsey ER – PersonEntity: Name: NameFull: Espay AJ – PersonEntity: Name: NameFull: Galifianakis NB – PersonEntity: Name: NameFull: Goldman SM – PersonEntity: Name: NameFull: Litvan I – PersonEntity: Name: NameFull: Luthra N – PersonEntity: Name: NameFull: McFarland NR – PersonEntity: Name: NameFull: Mitchell KT – PersonEntity: Name: NameFull: Standaert DG – PersonEntity: Name: NameFull: Bauer DC – PersonEntity: Name: NameFull: Greenspan SL – PersonEntity: Name: NameFull: Beck JC – PersonEntity: Name: NameFull: Lyles KW IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2021 Mar 01 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 2373-8057 Numbering: – Type: volume Value: 7 – Type: issue Value: 1 Titles: – TitleFull: NPJ Parkinson's disease Type: main |
| ResultId | 1 |